title: Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT.
abstract: Ovarian cancer represents one of the major form of cancer in women in the western world and its silent nature leads to a late clinical manifestation at advanced stage in many patients. Therefore the role of imaging techniques is very important for the correct management of these patients. In the present review, the role of 18F-FDG-PET/CT in the different clinical settings is presented and a comparison with other imaging modalities and serum biomarker CA-125 are discussed.
authors: Department of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy - mapelli.paola@hsr.it.
authors: Paola
authors: P
authors: Mapelli
authors: Elena
authors: E
authors: Incerti
authors: Federico
authors: F
authors: Fallanca
authors: Luigi
authors: L
authors: Gianolli
authors: Maria
authors: M
authors: Picchio
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood / Q000378:metabolism*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000378:metabolism* / Q000473:pathology; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods*; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D019788:Fluorodeoxyglucose F18